Methebac Tablet: Each tablet contains Methenamine Hippurate USP 1 g.
Methebac is indicated for prophylactic or suppressive treatment of
frequently recurring urinary tract infections when long-term therapy is
considered necessary. This drug should only be used after eradication
of the infection by other appropriate antimicrobial agents.
Dosage & Administration
1 tablet (1.0 g) twice daily (morning and night) for adults and paediatric
patients over 12 years of age. 1/2 to 1 tablet (0.5 to 1.0 g) twice daily
(morning and night) for paediatric patients 6 to 12 years of age. Since the
antibacterial activity of Methebac is greater in acid urine, restriction of
alkalinizing foods and medications is desirable or as directed by the
MyobacTM 5 Tablet : Each tablet contains Baclofen USP 5 mg.
MyobacTM 10 Tablet : Each tablet contains Baclofen USP 10 mg.
MyobacTM (Baclofen) is an effective muscle relaxant and
antispastic agent with a spinal site of action. It exerts its action by
inhibiting both monosynaptic and polysynaptic transmission in the
spinal cord by stimulating GABAB receptors.
MyobacTM (Baclofen) is indicated for the alleviation of spasticity
resulting from multiple sclerosis particularly for the relief of flexor
spasm and concomitant pain, clonus and muscular rigidity, spinal
cord diseases, muscle spasm of cerebral origin especially infantile
cerebral palsy, stroke or neoplastic or degenerative brain diseases.
It may be of some value in patients with trigeminal neuralgia,
tardive dyskinesia, cluster headache & tension type headache.
Dosage & Administration:
Muscle relaxant & spasticity
For adults: Start at a low dosage and increase gradually until the
optimum effect is achieved (usually 40-80mg daily). Initially 5 mg
three times daily for 3 days; then 10 mg three times daily for 3
days, 15 mg three times daily for 3 days and 20 mg three times
daily for 3 days. Additional increases in dose may be required but
should not exceed 20 mg four times daily.
For Children: (treatment of spasticity): 0.75-2 mg/kg daily (over 10
years, max. 2.5 mg/kg daily) or 2.5 mg 4 times daily increased
gradually according to age to maintenance: 1-2 years 10-20 mg
daily, 2-6 years 20-30 mg daily, 6-10 years 30-60 mg daily.
Or as directed by the physician.
MyobacTM (Baclofen) is contraindicated in patients who are
hypersensitive to any component of this preparation.
Warning and precaution:
Hallucinations and seizures may occur on abrupt withdrawal of
MyobacTM (Baclofen). Therefore, except for serious adverse
reactions, the dose should be reduced slowly when the drug is
Common side effects: Agitation, anxiety, ataxia, cardiovascular
depression, confusion, depression, dizziness, drowsiness, dry
mouth, euphoria, gastrointestinal disturbances, hallucinations,
headache, hypotension, insomnia and myalgia.
Rare side effects: Abdominal pain, changes in hepatic function, c,
paraesthesia and taste disturbances.
Momespray: Each spray delivers Mometasone Furoate BP 50 mcg.
Momespray is a corticosteroid demonstrating
anti-inflammatory properties. The precise mechanism of
corticosteroid action on allergic rhinitis is not known.
Corticosteroids have been shown to have a wide range of
effects on multiple cell types (e.g, mast cells, eosinophils,
neutrophils, macrophages, and lymphocytes) and
mediators (e.g, histamines, eicosanoids, leukotrienes,
and cytokines) involved in inflammation. Protein binding
for Mometasone Furoate was reported to be 98% to 99%
in concentration range of 5 to 500 ng/ml.The effective
plasma elimination half-life of Mometasone Furoate is 5.8
Momespray is indicated for the treatment of the nasal
symptoms of seasonal and perennial allergic rhinitis, in
adults and pediatric patients 2 years of age and older. It
is indicated for the prophylaxis of the nasal symptoms of
seasonal allergic rhinitis in adult and adolescent patients
12 years and older. It is also indicated for the treatment of
nasal polyps in patients 18 years and older.
Dosage & Administration
Administer Mometasone Nasal Spray by the intranasal
Adults and Children 12 Years of Age and Older: For
prophylaxis and treatment of the nasal symptoms of seasonal allergic rhinitis and treatment of the nasal symptoms of perennial allergic rhinitis use two sprays (50 mcg of Mometasone Furoate in each spray) in each nostril once daily (total daily dose of 100 mcg). In patients with a known seasonal allergen that precipitates nasal symptoms of seasonal allergic rhinitis, prophylaxis use
Momespray 50 mcg (200 mcg/day) 2 to 4 weeks prior to the anticipated start of the pollen season.
Children (2 to 11 years of age)
For treatment of the nasal symptoms of seasonal and perennial allergic rhinitis use one spray (50 mcg of Mometasone Furoate in each spray) in each nostril once daily (total daily dose of 100 mcg).
Adults 18 years of Age and Older: For nasal polyps use two sprays (50 mcg of Mometasone Furoate in each spray) in each nostril twice daily (total daily dose of 400 mcg). A dose of two sprays (50 mcg of mometasone furoate in each spray) in each nostril once daily (total daily dose of 200 mcg) is also effective in some patients or as directed by the physician.
Miracal-D is a prescription medicine. It is a combination of medicines that are prescribed to treat osteoporosis. It ensures the proper growth and functioning of the joints and bones. Miracal-D should be used in the dose and duration as prescribed by your doctor. It is advised to take this medicine at a fixed time. This medicine should not be taken in more than the recommended dose. This is usually a safe medicine with very minimal side effects but if you experience severe diarrhea, nausea, or vomiting or any symptoms of an allergic reaction, please consult your doctor. Before taking this medicine, tell your doctor if you have any other health conditions. Inform your doctor if you are taking any other medicines or if you are pregnant or breastfeeding.
Uses of Miracal-D
Miracal-D is a combination of two nutritional supplements: Calcium and Vitamin D3 which replenish the body's stores of important nutrients.
Magnesium Oxide is indicated in-
- Relieving the symptoms of magnesium deficiency.
- Rapid or irregular heart rate, heart attack, angina pectoris, mild or severe hypertension.
- Tetania, muscle cramp, gastrointestinal cramps, stress, increased stimulability of muscles and nerves, call cramps, and cramp in newborn and young children.
- Gynecological diseases, cervical insufficiency, eclampsia, pre-eclampsia, tocolysis, dysmenorrhea.
- Calcification and ossification
- Prevention of kidney stone formation
- Diabetes treatment and migraine
Magnesium belongs to the group of drugs called mineral support products. It occurs in nature in the form of the mineral periclase. Magnesium is required for energy production, oxidative phosphorylation, and glycolysis. In its purest form, magnesium oxide is a colorless or white crystalline material or very fine powder, with no odor and a bitter taste.
Magnesium helps to regulate diverse biochemical reactions in the body, including protein synthesis, muscle and nerve function, blood glucose control, and blood pressure regulation. It contributes to the structural development of bone and is required for the synthesis of DNA, RNA, and the antioxidant glutathione. Magnesium also plays a role in the active transport of calcium and potassium ions across cell membranes, a process that is important to nerve impulse conduction, muscle contraction, and normal heart rhythm.
The majority of magnesium is excreted renally.
Dosage & Administration
The recommended daily dose for adults and adolescents (12-17 years) is 1-2 tablets.
Aminoquinolones, Nitrofurantoin, Penicillamine, Tetracyclines, Fluoroquinolones, Digoxin, Lithium, Sodium polystyrene sulfonate, Nifedipine etc.
Contraindications Hypersensitivity and severe renal impairment.
- Stomach upset and diarrhea
- Paralytic ileus
- Muscle weakness
Pregnancy & Lactation
It should be used as directed by the physician during pregnancy and lactation.
Precautions & Warnings
Before taking a magnesium supplement, tell your doctor or pharmacist if you are allergic to it.
Symptoms of overdose may include slow heartbeat, severe dizziness, confusion, muscle weakness, loss of consciousness, diarrhea and hypermagnesemia.
Antacids, Electrolytes preparations, Oral electrolytes preparations
Keep out of reach of children. Store in a dry place, below 25°C temperature, and protected Irom light.
Each capsule contains Ferric Maltol INN
equivalent to Iron 30 mg.
Ferric Maltol delivers iron for uptake across the intestinal
wall and transfers to transferrin and ferritin. It has been
shown to increase serum iron parameters, including ferritin
and transferrin saturation. Ferric Maltol dissociates upon
uptake from the Gastrointestinal Tract allowing iron and
maltol to be absorbed separately. The iron is absorbed
across the intestinal wall and transfer to transferrin and
ferritin. It increases serum iron parameters, including ferritin
and transferrin saturation.
Total serum iron peak values were reached 1.5 to 3 hours
after administration. Food has been shown to decrease the
bioavailability of iron after administration of ferric maltol.
Around 60% of ferric maltol is excreted in the urine as
glucuronide conjugate. Iron and ferric maltol are not
excreted in the urine and unabsorbed ferric maltol is
eliminated in the feces.
It is indicated for the treatment of iron deficiency in adults.
Dosage & Administration
30 mg twice daily on an empty stomach (Morning &
• Continue as long as necessary to replenish body iron
stores or as directed by the physician.
It is contraindicated in patients with a history of:
• Hypersensitivity to the active substance or to any of the
• Hemochromatosis and other iron overload syndromes
• Receiving repeated blood transfusions.
Warnings & Precautions
Avoid use of Ferric Maltol in patients with an active
inflammatory bowel disease (IBD) flare, as there is potential
risk of increased inflammation in the gastrointestinal tract.
• Excessive therapy with iron drugs can lead to excess
storage of iron with the possibility of iatrogenic
• Accidental overdose of iron-containing drugs is a leading
cause of fatal poisoning in children under 6 years.
The most common side effects include gas, diarrhoea,
constipation, discolored stools, stomach pain, nausea or
vomiting and stomach area discomfort or bloating.
Use in Pregnancy & Lactation
In a clinical study, it has been found that oral use of Ferric
Iron in pregnant women indicate no malformative nor feto
toxicity. Ferric Maltol may be considered during pregnancy
There is no effects of oral Ferric Iron in breastfeed
newborns or infants of treated mother. Ferric Maltol can be
used during breastfeeding if clinically needed.
Use in Children & Adolescents
Safety and effectiveness of Ferric Maltol have not been
established in paediatric patients.
Dimercaprol: Concomitant use of iron products with
dimercaprol may increase the risk of nephrotoxicity.
The absorption of certain oral medications decreases such
as bisphosphonates, levodopa, thyroid medications and
tetracycline antibiotics when given together with iron.
Early signs and symptoms of iron overdosage may include
nausea, vomiting, abdominal pain and diarrhoea. In more
serious cases, hypoperfusion, metabolic acidosis and
systemic toxicity are observed. Dosages of excess iron may
lead to hemosiderosis.
Store below 30°C, away from light and in a dry place. Keep
all medicines out of reach of children.
Momespray™: Each spray contains Mometasone Furoate BP 50 meg.
Momespray™ is indicated for the treatment of the nasal symptoms of seasonal and perennial allergic rhinitis, in adults and pediatric patients 2 years of age and older. It
is indicated for the prophylaxis of the nasal symptoms of seasonal allergic rhinitis in adult and adolescent patients 12 years and older. It is also indicated for the treatment of
nasal polyps in patients 18 years and older.
Dose & Administration:
Administer Mometasone Nasal Spray by the intranasal route only.
Adults and Children 12 Years of Age and Older: For prophylaxis and treatment of the nasal symptoms of seasonal allergic rhinitis and treatment of the nasal
symptoms of perennial allergic rhinitis use two sprays (50 meg of Mometasone Furoate in each spray) in each nostril once daily (total daily dose of 100 meg). In patients
with a known seasonal allergen that precipitates nasal symptoms of seasonal allergic rhinitis, prophylaxis use Momespray™ 50 meg (200 meg/day) 2 to 4 weeks prior
to the anticipated start of the pollen season.
Children (2 to 11 years of age) For treatment of the nasal symptoms of seasonal and perennial allergic rhinitis use one spray (50 meg of Mometasone Furoate in each spray) in each nostril once daily (total daily dose of 100 meg).
Adults 18 years of Age and Older: For nasal polyps use two sprays (50 meg of Mometasone Furoate in each spray) in each nostril twice daily (total daily dose of 400
meg). A dose of two sprays (50 meg of mometasone furoate in each spray) in each nostril once daily (total daily dose of 200 meg) is also effective in some patients.
Meltix™ Tablet: Each film coated tablet contains Flupentixol
Dihydrochloride BP equivalent to 0.5 mg Flupentixol and Melitracen Hydrochloride INN equivalent to 10 mg Melitracen.
It is indicated in various types of anxiety, depression and apathy.
These include-) Psychogenic depression
a. Depressive neurosis
b. Masked depression
c. Psychosomatic affections accompanied by anxiety and apathy.
d. Menopausal depressions
e. Dysphoria and depression in alcoholics and drug-addicts.
Dosage & Administration:
Adults : Usually 2 tablets daily at morning and noon. In severe cases the
morning dose may be increased to 2 tablets.
Elderly patients : 1 tablet in the morning.
Maintenance dose : Usually 1 tablet in the morning. In cases of insomnia or severe restlessness additional treatment with a sedative in acute phase is recommended. Or as directed by the physician.